Skip to main content

Table 1 Design of peptides used in the construction of the PDDVs.

From: The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy

Code

Amino acid sequence of 18 Lys and the 18 Lys fused epitopes synthesized for PDDV formulations

Oligonucleotide sequences used for plasmid construction

Source

Epitope type

18K

KKKKKKKKKKKKKKKKKK

None

None

None

C1

KKKKKKKKKKKKKKKKKKNLMKENKNL

5'-tcgacatgaatcttatgaaagaaaataagaatttag-3'

Sj 97

(555-563)

CTL

  

5'-aattctaaattcttattttctttcataagattcatg-3'

  

C2

KKKKKKKKKKKKKKKKKKVRAVANDLK

5'-tcgacatggtaagagcggtggcaaatgacttaaaag-3'

Sj 22.6

(134-142)

CTL

  

5'-aattcttttaagtcatttgccaccgctcttaccatg-3'

  

C3

KKKKKKKKKKKKKKKKKKATRLNNEVL

5'-tcgacatggcaactagattgaataatgaagttttgg-3'

Sj 97

(672-680)

CTL

  

5'-aattccaaaacttcattattcaatctagttgccatg-3'

  

T2

KKKKKKKKKKKKKKKKKKITELEDVAERERLKA

5'-tcgacatgatcactgaacttgaagatgttgcagagagagaacgattaaaagcgg-3'

Sj 97

(313-327)

Th-cell

  

5'-aattccgcttttaatcgttctctctctgcaacatcttcaagttcagtgatcatg-3'

  

T3

KKKKKKKKKKKKKKKKKKAKQYNICCKFKELLD

5'-tcgacatggctaagcaatataacatatgttgtaaatttaaagaacttctcgatg-3'

Sj22.6

(111-125)

Th-cell

  

5'-aattcatcgagaagttctttaaatttacaacatatgttatattgcttagccatg-3'

  

B1

KKKKKKKKKKKKKKKKKKEQRLRERDEELESLRKSTTRTI

5'-tcgacatggaacagagacttagagaaagagatgaagaattagaaagtctaagaaagagtacaactagaacaatattg-3'

Sj 97 (489-510)

B-cell

  

5'-aattcaatattgttctagttgtcatctttcttagactttctaattcttcatctctttctctaagtctctgttccatg-3'

  

B2

KKKKKKKKKKKKKKKKKKWEVRREKEELKKDKEGKVSTL

5'-tcgacatgtgggaagtccgtcgtgaaaaggaagaattaaagaaagacaaggaaggcaaagtatccacacttg-3'

Sj 22.6 (77-97)

B-cell

  

5'-aattcaagtgtggatactttgccttccttgtctttctttaattcttccttttcacgacggacttcccacatg-3'

  

B3

KKKKKKKKKKKKKKKKKKRQEEEMKKAAEELAKLKEEFEK

5'-tcgacatgcgtcaggaagaagaaatgaagaaagcagccgaagaattagctaaactaaaagaagaatttgaaaaag-3'

Sj 62 (167-188)

B-cell

  

5'-aattctttttcaaattcttcttttagtttagctaattcttcggctgctttcttcatttcttcttcctgacgcatg-3'

 Â